Pancreatic Cancer Takes Spotlight at the Passing of Steve Jobs


Pancreatic cancer is a rare and almost always fatal form of cancer that lacks effective pre-screening methods and treatment options.

While his cause of death has yet to be released to the public, Steve Jobs, Co-Founder and Chairman of the Board of Apple, Inc., who suffered from pancreatic cancer since 2004, passed away on October 5, 2011.

"While Steve Jobs battled a rare form of pancreatic cancer (pancreatic neuroendocrine tumor), his passing, if due to pancreatic cancer, is a stark reminder of the severity of this deadly cancer and lack of effective treatment options available to patients. Even those with the greatest access to treatments and the highest level of care cannot defeat this insidious disease,” says Julie Fleshman, President and CEO of the Pancreatic Cancer Action Network.

Whenever a high profile person passes away to pancreatic cancer, it ironically builds awareness and interest about a disease that not many know, or understand. “To make progress against this disease, it is critical to know it and fight it, so one day we can end it,” says Fleshman.

The Pancreatic Cancer Action Network extends their deepest sympathy to the family of Steve Jobs, his friends and collegues, and the entire Apple community. He was an American icon and one of the greatest visionaries of our time.

To learn more about the Pancreatic Cancer Action Network, go to